ICON Web & News
Virtual Journal
Everything
Resources
Virtual Journal
Analyze Database
GoodNanoGuide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports
Ratings Comment
Guidelines
Links
Quick Search:
Keywords:
Search:
Search Using OECD Database
Details
Return to Previous Page
Addition or Correction
Title:
Effects of surfactants on the properties of PLGA nanoparticles
Date:
8/2012
Link to Journal Abstract
Abstract:
The objective of this study was to investigate the physical characteristics of poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) coated with two surfactants, Pluronic or the commonly used polyvinyl alcohol (PVA); and determine their in vitro efficiency as drug carriers for cancer therapy. Free surfactant cytotoxicity results indicated that Pluronic F127 (PF127) was most cytocompatible among the Pluronics tested and hence chosen for coating PLGA NPs for further studies. Release studies using doxorubicin (DOX) as a drug model showed sustained release of DOX from both PVA- and PF127-coated PLGA NPs (PLGA-PVA and PLGA-PF127, respectively) over 28 days. Further, there was no significant difference in human dermal fibroblasts and human aortic smooth muscle cell survival when exposed to both types of NPs. Cellular uptake studies demonstrated that uptake of both nanoparticle types was dose-dependent for both prostate and breast cancer cells. However, these cancer cells internalized more PLGA-PF127 NPs than PLGA-PVA NPs. Moreover, studies showed that drug-loaded PLGA-PF127 NPs not only killed more cancer cells than drug-loaded PLGA-PVA NPs, but also overcame drug resistance in LNCaP, MDA-MB-231, and MDA-MB-468 cancer cells on re-exposure. These results indicate that PLGA-PF127 NPs can form a promising system that not only delivers anti-cancer drugs, but also overcomes drug resistance, which is prevalent in most cancer cells.
Non-technical Summary:
The objective of this study was to investigate the physical characteristics of poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) coated with two surfactants, Pluronic or the commonly used polyvinyl alcohol (PVA); and determine their in vitro efficiency as drug carriers for cancer therapy.
Content Emphasis
Peer Reviewed Journal Article
Exposure Or Hazard Target
Mammalian
Exposure Pathway
Other/Unspecified
Method Of Study
In Vitro
Paper Type
Hazard
Particle Type
Organic/Polymers
Production Method
Engineered
Risk Exposure Group
General Population
Target Audience
Technical Research
Citation:
Journal of Biomedical Materials Research, 100A(8): 1998-2005 (August 2012)
Publication:
Journal of Biomedical Materials Research Part A
Author:
Menon JU, Kona S, Wadajkar AS, Desai F, Vadla A, Nguyen KT
Volume:
100A
Number:
8
Pages:
1998-2005
Last updated on January 15, 2013
Permalink
Join Us
|
About
|
Newsroom
|
Working Groups
|
Projects
|
Resources
|
Virtual Journal
|
Events
|
Logout
This work is supported in part by the Nanoscale Science and Engineering Initiative of the National Science Foundation
under NSF Award Number EEC-0118007.
Why Join Us?
Mission and Strategy
Background
Organization
Sponsors
Participants
Contact Us
ICON Releases
News
Media Alert
RSS
Governance
Knowledge Base
Best Practices
Communications
Virtual Journal
Analyze Database
Good Nano Guide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports
Links
Council Events
Other Events
Virtual Journal
Analyze Database
The GoodNanoGuide
Nano EHS Research Needs
Current Practices Survey